Dual SGLT1/2 Inhibitor Protects Against MI and Stroke ...Middle East

News by : (Medscape) -
Sotagliflozin, a dual SGLT1/2 inhibitor, reduces cardiovascular events in people with diabetic kidney disease — ischemic benefits not observed in trials of selective SGLT2 inhibitors. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Dual SGLT1/2 Inhibitor Protects Against MI and Stroke )

Also on site :

Most Viewed News
جديد الاخبار